Thank you for your introduction,thank DIA inviting me to come to this conference.After knowing so many data,I am very happy to learn some details about traditional Chinese medicine (TCM),including China's efforts ...Thank you for your introduction,thank DIA inviting me to come to this conference.After knowing so many data,I am very happy to learn some details about traditional Chinese medicine (TCM),including China's efforts in TCM,and what has been done in Europe.I would like to tell you about some of the challenges of TCM from the perspective of the European Union (EU).Many of them are mentioned by previous speakers.In fact,there are ways to allow herbs to enter the European market.Traditional herbal products have been established.And there is a full market authorization.Traditionally,it is necessary to ensure their medicinal efficacy and safety.Clinical trials are not necessary for every circumstance,but 10 years of use history within the EU is necessary.This is the process of full marketing.The USA and Europe have a similar situation: 3 of the 4 phases are required before the marketing authorization.These are 3 examples: a newly developed drug in Europe,it is from gentian roots,primrose,sorrel and other drugs,mainly for rhinitis;this is from Switzerland,which is from an extract of coltsfoot flowers;Schwabe's is from lavender,used for anxiety,and this is its name in Australia.展开更多
文摘Thank you for your introduction,thank DIA inviting me to come to this conference.After knowing so many data,I am very happy to learn some details about traditional Chinese medicine (TCM),including China's efforts in TCM,and what has been done in Europe.I would like to tell you about some of the challenges of TCM from the perspective of the European Union (EU).Many of them are mentioned by previous speakers.In fact,there are ways to allow herbs to enter the European market.Traditional herbal products have been established.And there is a full market authorization.Traditionally,it is necessary to ensure their medicinal efficacy and safety.Clinical trials are not necessary for every circumstance,but 10 years of use history within the EU is necessary.This is the process of full marketing.The USA and Europe have a similar situation: 3 of the 4 phases are required before the marketing authorization.These are 3 examples: a newly developed drug in Europe,it is from gentian roots,primrose,sorrel and other drugs,mainly for rhinitis;this is from Switzerland,which is from an extract of coltsfoot flowers;Schwabe's is from lavender,used for anxiety,and this is its name in Australia.
